Regeneron Receives Emergency Use Authorization For Covid Antibody Cocktail
November 22, 2020 at 11:23 AM EST
Regeneron Pharmaceuticals announced that the antibody cocktail casirivimab and imdevimab administered together, a therapy currently being investigated for use in COVID-19, received Emergency Use Authorization from the Food and Drug Administration.